Terminated PHASE2 INTERVENTIONAL 2-arm NCT03195010

Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia

Management of Venous Thromboembolic Events (VTE) in Patients With Hematologic Disorders and Treatment-Induced Thrombocytopenia: A Pilot Study

Sponsor: Fred Hutchinson Cancer Center

Conditions Acute Biphenotypic Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia B-Cell Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Hematologic and Lymphocytic Disorder Hematopoietic Cell Transplantation Recipient Myelodysplastic Syndrome Primary Myelofibrosis Secondary Myelofibrosis T-Cell Non-Hodgkin Lymphoma Thrombocytopenia Venous Thromboembolism

Interventions Platelet Transfusion

Updated 12 times since 2017 Last updated: Oct 17, 2019 Started: Jun 9, 2017 Primary completion: Dec 21, 2018 Completion: Dec 21, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Terminated because of slow recruitment and lack of funding support

Other terminated trials from Fred Hutchinson Cancer Center

See all terminations from Fred Hutchinson Cancer Center

A PHASE2 clinical study on Acute Biphenotypic Leukemia and Acute Lymphoblastic Leukemia, this trial is terminated or withdrawn. The trial is conducted by Fred Hutchinson Cancer Center and has accumulated 12 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE2
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE2
May 2022 — Dec 2022 [monthly]

Terminated PHASE2

▶ Show 7 earlier versions

Jan 2021 — May 2022 [monthly]

Terminated PHASE2
Nov 2019 — Jan 2021 [monthly]

Terminated PHASE2
Feb 2019 — Nov 2019 [monthly]

Terminated PHASE2

Status: Enrolling By Invitation → Terminated
Dec 2018 — Feb 2019 [monthly]

Enrolling By Invitation PHASE2
Jun 2018 — Dec 2018 [monthly]

Enrolling By Invitation PHASE2
Feb 2018 — Jun 2018 [monthly]

Enrolling By Invitation PHASE2
Jul 2017 — Feb 2018 [monthly]

Enrolling By Invitation PHASE2

First recorded

Jun 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Data source: Fred Hutchinson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seattle, United States